Pardes Biosciences (PRDS) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free PRDS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePardes Hanna, Israel - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - October 31 at 1:12 PMPardes Biosciences Announces Closing of Tender Offerfinance.yahoo.com - August 31 at 9:39 AMmarketbeat.com - August 31 at 6:01 AMMediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciencesfinance.yahoo.com - August 28 at 1:21 PMMediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Sharesfinance.yahoo.com - August 17 at 6:38 PMPardes Biosciences (PRDS) Price Target Decreased by 28.57% to 1.28msn.com - August 3 at 9:10 PMPardes Biosciences Shares Rise 15% After Buyout Offer From MediPacificmarketwatch.com - July 19 at 4:18 PMSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pardes Bioscience, Inc. (PRDS)markets.businessinsider.com - July 19 at 4:18 PMJMP Securities Downgrades Pardes Biosciences (PRDS)msn.com - July 18 at 5:51 PMPRDS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Pardes Biosciences, Inc. Is Fair to Shareholdersbenzinga.com - July 17 at 3:27 PMPardes Biosciences stock rallies on buyout offer from MediPacificmsn.com - July 17 at 10:26 AMWhy Pardes Biosciences Shares Are Rising Mondaybenzinga.com - July 17 at 10:26 AMPardes Biosciences To Be Acquired By MediPacific; Pardes Up In Pre-marketmarkets.businessinsider.com - July 17 at 10:26 AMPardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rightsfinance.yahoo.com - July 17 at 10:26 AMmarketbeat.com - July 17 at 6:56 AMAll You Need to Know About Pardes Biosciences, Inc. (PRDS) Rating Upgrade to Buyfinance.yahoo.com - June 5 at 5:45 PMPardes Biosciences Seeking Strategic Alternativesseekingalpha.com - May 17 at 11:43 PMPardes Biosciences (PRDS) Receives a Hold from SVB Securitiesmarkets.businessinsider.com - May 9 at 7:23 AMPardes Biosciences Inc.barrons.com - May 6 at 11:25 PMPardes Biosciences, Inc: Pardes Biosciences Reports First Quarter 2023 Financial Resultsfinanznachrichten.de - May 6 at 8:24 AMRecap: Pardes Biosciences Q1 Earningsmsn.com - May 5 at 8:30 PMPardes Biosciences Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 5 at 8:30 PMAnalyst Rating: Will Pardes Biosciences Inc (PRDS) Stock Do Better Than the Market?benzinga.com - April 12 at 6:58 PMPardes Biosciences cut at Jefferies on COVID drug failureseekingalpha.com - April 7 at 12:22 AMSVB Leerink Downgrades FS Development Corp II (PRDS)msn.com - April 4 at 10:58 PMSVB Securities downgrades Pardes Biosciences (PRDS) to a Holdmarkets.businessinsider.com - April 4 at 7:37 AMPardes slumps ~10% after COVID drug trial failure prompts strategic reviewmsn.com - April 3 at 4:26 PMPardes Biosciences Looks For Alternatives After Failed COVID-19 Studymsn.com - April 3 at 4:26 PMWill Pardes Biosciences (NASDAQ:PRDS) Spend Its Cash Wisely?finance.yahoo.com - April 3 at 9:42 AMPardes Biosciences to suspend COVID-19 drug development after mid-stage trial failsreuters.com - April 3 at 9:42 AMPardes Biosciences Announces Top-line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of COVID-19finance.yahoo.com - April 3 at 9:42 AMmarketbeat.com - April 3 at 7:57 AMSVB Securities Reaffirms Their Buy Rating on Pardes Biosciences (PRDS)markets.businessinsider.com - March 20 at 10:22 AMPardes Biosciences Stock (NASDAQ:PRDS), Guidance and Forecastbenzinga.com - March 16 at 4:53 AMPardes Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updatefinance.yahoo.com - March 14 at 4:18 PMPardes Biosciences to Present at SVB Securities Global Biopharma Conferencefinance.yahoo.com - February 1 at 10:42 AMRM LAW Announces Investigation of Pardes Biosciences, Inc.prnewswire.com - January 30 at 7:16 PMIeq Capital LLC Invests $105,000 in Pardes Biosciences, Inc. (NASDAQ:PRDS)marketbeat.com - January 30 at 5:35 AMPardes Biosciences, Inc. to Post FY2026 Earnings of $4.35 Per Share, SVB Leerink Forecasts (NASDAQ:PRDS)marketbeat.com - January 30 at 2:55 AMPardes Biosciences (NASDAQ:PRDS) PT Lowered to $9.00marketbeat.com - January 27 at 8:30 AMPRDS Pardes Biosciences, Inc.seekingalpha.com - January 25 at 1:41 PM(SPAC) Special Purpose Acquisition Investigation: KIND, OPFI, OTMO, PRDS, Contact Shareholder Rights Law Firm Johnson Fistelbenzinga.com - January 14 at 10:22 PMPardes Biosciences, Inc. (NASDAQ:PRDS) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - November 13 at 6:59 PMPardes Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Updateapnews.com - November 8 at 12:02 PMPardes Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - November 8 at 12:02 PMPardes Biosciences to Present at Jefferies London Healthcare Conferencefinance.yahoo.com - November 1 at 2:24 PMHere's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situationfinance.yahoo.com - September 28 at 5:11 PMPardes Biosciences Appoints Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to Board of Directorsfinance.yahoo.com - September 14 at 12:50 PMPardes Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 12 at 10:43 AMPardes Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 12 at 10:43 AM Get Pardes Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PRDS and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. PRDS Media Mentions By Week PRDS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRDS News Sentiment▼0.000.50▲Average Medical News Sentiment PRDS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRDS Articles This Week▼00▲PRDS Articles Average Week Get Pardes Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PRDS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kinnate Biopharma News Theseus Pharmaceuticals News Global Technology Acquisition Corp. I News Moolec Science News Fortress Biotech News LianBio News Innovid News Harpoon Therapeutics News Computer Programs and Systems News CytomX Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRDS) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pardes Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.